Antidepressant use in pregnancy: are we closer to consensus?
Explore this paper's citation graph
Summary
Significant data from recent large studies are specified and summarized in a tool to aim at consensus on the question of whether and how serotonin-reuptake antidepressants should be used in pregnancy, on the basis that concern for the mental health of the mother should not vie for primacy with concerns for the child's health, but must be best served together.
- Type
- review
- Published
- 2018-08-20
- Cited by
- 10
- References
- 68
- OpenAlex
- https://openalex.org/W2888516689
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:52047075
Keywords
Antidepressant, Pregnancy, Mental health, Psychiatry, Serotonin reuptake inhibitor
References
- Antenatal Depression, Treatment with Selective Serotonin Reuptake Inhibitors, and Neonatal Brain Structure: A Propensity-Matched Cohort Study
- Maternal perinatal and concurrent depressive symptoms and child behavior problems: a sibling comparison study
- Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study
- [Growth references for Norwegian children].
- Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?
- Reasons for Rehospitalization in Children Who Had Neonatal Abstinence Syndrome
- Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn
- The use of psychotropic medication during pregnancy: how about the newborn?
- Maternal prenatal anxiety and downregulation of placental 11β-HSD2.
- Neonatal Adaptation in Infants Prenatally Exposed to Antidepressants- Clinical Monitoring Using Neonatal Abstinence Score
- Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children
- Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
- Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome
- A meta-analysis of treatments for perinatal depression
- The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta‐analysis of direct comparisons
- Fact: antidepressants and anxiolytics are not safe during pregnancy.
- The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists,
- The effects of antenatal depression and antidepressant treatment on placental gene expression
- Controversies About the Use of Antidepressants in Pregnancy
- A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight
Cited by
- Differential effects of fluoxetine and venlafaxine in the neural embryonic stem cell test (ESTn) revealed by a cell lineage map.
- Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review.
- Preventive Cognitive Therapy With Antidepressant Discontinuation During Pregnancy: Results From a Randomized Controlled Trial.
- To evaluate the effects of antidepressant drugs on pregnancy outcomes in a university hospital of Turkey.
- Is aromatherapy effective in obstetrics? A systematic review and meta‐analysis
- Antidepressants and Psychological Treatment: Hard Reasons for Synergy
- The impact of antidepressants on human neurodevelopment: Brain organoids as experimental tools.
- Investigation of Hypothalamic Pituitary Adrenal Axis and Oxytocinergic System Changes in a Pragmatic Randomized Controlled Feasibility Trial of Acupuncture for Antenatal Depression
- Sex-Specific Neuropsychiatric Effects of Subanesthetic Ketamine Exposure in Pregnant Mice and Their Offspring
- Trajectories of Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Perinatal Outcomes: A Longitudinal Register Study
Related papers
- A 6-year longitudinal study: Are maternal depressive symptoms and Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant treatment during pregnancy associated with everyday measures of executive function in young children?
- Selective Serotonin Reuptake Inhibitor (SSRI) Efficiency, and Comparison to Alternative Antidepressant Treatments
- Biological and behavioural antidepressant treatment responses with the selective serotonin reuptake inhibitor fluoxetine can be determined by the environment
- Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
- Antidepressant-like effect of hyperbaric oxygen treatment in forced-swimming test in rats.
- Vortioxetine: A multimodal antidepressant or another selective serotonin reuptake inhibitor?
- Do Selective Serotonin Reuptake Inhibitor Antidepressant Drugs Promote Atherosclerosis?
- Anti-inflammatory drugs as moderators of antidepressant effects, especially those of the selective serotonin-reuptake inhibitor class
- Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
- Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: A review of findings in humans and rodent models.